Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

NCT00910520 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

548

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

BIOLOGICAL: onabotulinumtoxinA
DRUG: normal saline

Sponsor

Allergan